Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02086630 · ClinicalTrials.gov registry record · Phase 1
Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline
A Phase 1 study, sponsored by New York University.
- Completed
- Registry status
- Phase 1
- Development phase
- 95
- Enrollment target
NCT02086630 is a Phase 1 study that has completed, run by New York University. The registered enrollment target is 95 participants.
The verdict
NCT02086630, a Phase 1 study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 95 participants
- Enrollment target
Study Summary
This study addresses racial/ethnic disparities in HIV/AIDS treatment. Many persons living with HIV/AIDS (PLHA) in the U.S. (10-19% of PLHA), predominantly African-Americans and Latinos, delay taking Highly Active Antiretroviral Therapy (HAART) until late in the course of their HIV disease or never initiate HAART when it is medically indicated. However, there are no behavioral interventions to increase HAART initiation among PLHA who delay or decline HAART ("PLHA-DD"). The overarching aim of the proposed study is to develop a flexible, targeted, and sustainable behavioral intervention to increase HAART initiation among PLHA-DD, which, if efficacious, will lead to reductions in morbidity, early mortality, and health care costs, as well as increased viral load suppression (reducing transmission to others). Further, the study complements and primes participants for existing adherence interventions, from which PLHA-DD can benefit when they initiate HAART.
Interventions
- BEHAVIORAL Heart to Heart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2012-05 |
| Est. Completion | 2015-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02086630
The ClinicalTrials.gov registry entry for NCT02086630 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Heart to Heart is the first listed.
NCT02086630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02086630 about?
NCT02086630 is a clinical study titled "Timely Initiation of HIV Antiretroviral Therapy Among Those Who Delay/Decline". This study addresses racial/ethnic disparities in HIV/AIDS treatment. Many persons living with HIV/AIDS (PLHA) in the U.S. (10-19% of PLHA), predominantly African-Americans and Latinos, delay taking Highly Active Antiretroviral Therapy (HAART) until late in the course of their HIV disease or never i...
What is the current status of trial NCT02086630?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 95 participants. The study started on 2012-05. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02086630?
The interventions under investigation include: Heart to Heart (BEHAVIORAL).
Who is sponsoring clinical trial NCT02086630?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.